Sun Yong Lee

Dr. Sun Yong Lee

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2016 in Advanced Functional Materials
Verified
Journal Article
Closed access
PDF file
Ki Chang KwonKi Chang Kwon
Ki Chang Kwon
KHKootak Hong
Kootak Hong
Quyet Van LeQuyet Van Le
Quyet Van Le
SLSun Yong Lee
Sun Yong Lee
JCJaeho Choi
Jaeho Choi
Ho Won JangHo Won Jang
Ho Won Jang

26 October 2023 in EP Europace
Verified
Journal Article
Open access
PDF file
ZAZaki Akhtar
Zaki Akhtar
CKChristos Kontogiannis
Christos Kontogiannis
GGGeorgios Georgiopoulos
Georgios Georgiopoulos
CSChristoph Starck
Christoph Starck
LLLisa Leung
Lisa Leung
MGMark Michael Gallagher
Mark Michael Gallagher
Transvenous lead extraction (TLE) is performed using non-laser and laser techniques with overall high efficacy and safety. Variation in outcomes between the two approaches does exist with limited comparative evidence in the literature. We sought to compare non-laser and laser TLE in a meta-analysis. We searched Medline, Embase, Scopus, ClinicalTrials.gov, and CENTRAL databases for TLE studies published between 1991 and 2021. From the included 68 studies, safety and efficacy data were carefully evaluated and extracted. Aggregated cases of outcomes were used to calculate odds ratio (OR), and pooled rates were synthesized from eligible studies to compare non-laser and laser techniques. Subgroup comparison of rotational tool and laser extraction was also performed. Non-laser in comparison with laser had lower procedural mortality (pooled rate 0% vs. 0.1%, P < 0.01), major complications (pooled rate 0.7% vs. 1.7%, P < 0.01), and superior vena cava (SVC) injury (pooled rate 0% vs. 0.5%, P < 0.001), with higher complete success (pooled rate 96.5% vs. 93.8%, P < 0.01). Non-laser comparatively to laser was more likely to achieve clinical [OR 2.16 (1.77–2.63), P < 0.01] and complete [OR 1.87 (1.69–2.08), P < 0.01] success, with a lower procedural mortality risk [OR 1.6 (1.02–2.5), P < 0.05]. In the subgroup analysis, rotational tool compared with laser achieved greater complete success (pooled rate 97.4% vs. 95%, P < 0.01) with lower SVC injury (pooled rate 0% vs. 0.7%, P < 0.01). Non-laser TLE is associated with a better safety and efficacy profile when compared with laser methods. There is a greater risk of SVC injury associated with laser sheath extraction.

24 April 2013 in The Breast Journal
Verified
Journal Article
Open access
PDF file
JBJulianne R. Biroschak
Julianne R. Biroschak
GSGordon F. Schwartz
Gordon F. Schwartz
JPJuan P. Palazzo
Juan P. Palazzo
ATAdam D. Toll
Adam D. Toll
KBKristin L. Brill
Kristin L. Brill
SLSun Yong Lee
Sun Yong Lee
Oncotype DX, a gene-expression profiling assay, provides stratification of patients with estrogen-receptor positive, lymph-node-negative early breast cancer into risk groups based on recurrence score, which are associated with distant recurrence and response to chemotherapy. This study aims to determine whether Oncotype DX influences clinicians' treatment decisions, and whether assay results correlate with histologic assessment. Fifty patients with estrogen-receptor positive, node-negative early breast cancer analyzed by Oncotype DX and operated on by two breast surgeons were included. To assess effect on treatment decisions, clinical vignettes were created by retrospective chart review. Physicians were then presented with the clinical vignettes and instructed to make a treatment decisions (i.e., hormone therapy alone versus hormone therapy combined with chemotherapy) both before and after knowledge of the recurrence score. To assess correlation with histologic assessment, a prospective, blinded review of tumor slides was performed by two pathologists. Based on this review, tumors were placed into low, intermediate and high risk groups for comparison with Oncotype DX assay results. Treatment decisions were changed based on Oncotype DX results in 36 and 18% of cases by breast surgeons and medical oncologists, respectively. All tumors categorized as high risk by Oncotype DX were categorized as high risk based on histologic assessment, and 96% of cases categorized as low risk by recurrence score were categorized as low or intermediate risk by histologic assessment. Oncotype DX significantly influences management of estrogen-receptor positive, lymph-node-negative early breast cancer. Further studies are needed to assess association of histologic categorization to assay results.

4 July 2019 in Journal of Community Hospital Internal Medicine Perspectives
Verified
Journal Article
Open access
SLSun Yong Lee
Sun Yong Lee
CSChirag A. Sheth
Chirag A. Sheth
Eruptive xanthoma is characterized by yellowish skin papules encircled by an erythematous halo and associated with severe hypertriglyceridemia above 2,000 mg/dl. Hypertriglyceridemia can be caused by primary genetic mutations, secondary causes, such as uncontrolled diabetes, obesity, alcohol overuse, or combinations of both. Eruptive xanthoma can serve as an important clinical indicator of underlying systemic conditions (e.g. hypertriglyceridemia and uncontrolled diabetes mellitus). It is important for clinicians to recognize it to prevent further complications such as pancreatitis and cardiovascular disease.

27 November 2021 in Journal of Interventional Cardiac Electrophysiology
Verified
Journal Article
Open access
PDF file
SLSun Yong Lee
Sun Yong Lee
IAIsabel E. Allen
Isabel E. Allen
CDCelso Diaz
Celso Diaz
XGXiaofan Guo
Xiaofan Guo
CPCara Pellegrini
Cara Pellegrini
BLByron K. Lee
Byron K. Lee
Background: Rotating and laser sheaths are both routinely used in transvenous lead extraction (TLE) which can lead to catastrophic complications including death. The efficacy and risk of each approach are uncertain. To perform a meta-analysis to compare success and mortality rates associated with rotating and laser sheaths.Methods: We searched electronic academic databases for case series of consecutive patients and randomized controlled trials published 1998–2017 describing the use of rotating and laser sheaths for TLE. Among 48 studies identified, rotating sheaths included 1,094 patients with 1,955 leads in 14 studies, and laser sheaths included 7,775 patients with 12,339 leads in 34 studies. Patients receiving rotating sheaths were older (63 versus 60 years old) and were more often male (74% versus 72%); CRT-P/Ds were more commonly extracted using rotating sheaths (12% versus 7%), whereas ICDs were less common (37% versus 42%),p > 0.05 for all. Infection as an indication for lead extraction was higher in the rotating sheath group (59.8% versus 52.9%,p = 0.002). The mean time from initial lead implantation was 7.2 years for rotating sheaths and 6.3 years for laser sheaths (p > 0.05).Results: Success rates for complete removal of transvenous leads were 95.1% in rotating sheaths and 93.4% in laser sheaths (p < 0.05). There was one death among 1,094 patients (0.09%) in rotating sheaths and 66 deaths among 7,775 patients (0.85%) in laser sheaths, translating to a 9.3-fold higher risk of death with laser sheaths (95% CI 1.3 to 66.9,p = 0.01).Conclusions: Laser sheaths were associated with lower complete lead removal rate and a 9.3-fold higher risk of death.

1 March 2021 in Circulation: Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
SLSun Yong Lee
Sun Yong Lee
AFAmir Farid
Amir Farid
RDRamesh Dharawat
Ramesh Dharawat
SJSyung Min Jung
Syung Min Jung
EAEdris Aman
Edris Aman
CWCharles Whitcomb
Charles Whitcomb